A detailed history of Verus Capital Partners, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Verus Capital Partners, LLC holds 469 shares of TMO stock, worth $245,779. This represents 0.03% of its overall portfolio holdings.

Number of Shares
469
Previous 456 2.85%
Holding current value
$245,779
Previous $252,000 15.08%
% of portfolio
0.03%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$531.86 - $624.21 $6,914 - $8,114
13 Added 2.85%
469 $290,000
Q2 2024

Aug 01, 2024

BUY
$541.52 - $599.02 $30,325 - $33,545
56 Added 14.0%
456 $252,000
Q1 2024

May 07, 2024

BUY
$528.82 - $599.43 $211,528 - $239,771
400 New
400 $232,000
Q1 2022

Aug 09, 2022

SELL
$524.0 - $644.92 $448,020 - $551,406
-855 Closed
0 $0
Q1 2020

May 26, 2020

BUY
$255.3 - $340.05 $255 - $340
1 Added 0.12%
855 $242,000
Q4 2019

Feb 27, 2020

BUY
$271.93 - $328.04 $232,228 - $280,146
854 New
854 $278,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $205B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Verus Capital Partners, LLC Portfolio

Follow Verus Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verus Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verus Capital Partners, LLC with notifications on news.